Key facts
- This page summarizes Mark Patrick Guerin's Form 4 filing for Onconova Therapeutics, Inc. (TRAW).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Aug 2022, 16:38.
Mark Patrick Guerin - 02 Aug 2022 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)
- Reporting relationship
- CFO AND COO
- Issuer ticker
- TRAW
- Reported as of
- 02 Aug 2022
- Net transaction value
- -$1,789
- SEC form
- 4
- Accepted by SEC
- 04 Aug 2022, 16:38:24 UTC
- Prior SEC filing
- 13 Jun 2022
- Next SEC filing
- 08 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Guerin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark Patrick Guerin filed Form 4 for Onconova Therapeutics, Inc. (TRAW) on 04 Aug 2022.
Change
- Previous filing in this sequence was filed on 13 Jun 2022.
- Current net transaction value: -$1,789.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ONTX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +4,750
- Change %
- +49%
- Price
- Shares after
- 14,431
- Date
- 02 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
ONTX
transaction
Common Stock
Tax liability
- Transaction value
- $1,789
- Shares
- -1,355
- Change %
- -9.4%
- Price
- $1.32
- Shares after
- 13,076
- Date
- 03 Aug 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ONTX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,750
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 9,500
- Date
- 02 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,750
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.